Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.
The World Health Organization's Global Tuberculosis Report 2014, published recently shows that 9 million people developed TB in 2013, and 1.5 million died, revealing that there are almost half a million more cases of the disease than previously estimated.
